Latest news with #DSK
Bloomberg
18-07-2025
- Business
- Bloomberg
Novo's Wegovy Demand Raises Grocer Fears Over Denmark Food Sales
In Novo Nordisk A/S's home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local retailers are now warning they will take a hit as food consumption declines. Danish supermarkets could lose as much as 1.2 billion kroner ($187 million) in annual revenue as GLP-1-based drugs, like Novo's Wegovy, become more widely used, according to a fresh analysis by DSK, a trade association for Danish grocers. The loss could turn out to be even deeper if the medicine becomes cheaper or more accessible, such as through a tablet form, the group said.
Business Insider
19-05-2025
- Business
- Business Insider
Dusk Group Ltd. (DSK) Receives a Buy from Canaccord Genuity
Canaccord Genuity analyst Allan Franklin maintained a Buy rating on Dusk Group Ltd. (DSK – Research Report) on May 16 and set a price target of A$1.40. The company's shares closed last Friday at A$0.86. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter According to TipRanks, Franklin is an analyst with an average return of -2.4% and a 35.53% success rate. Currently, the analyst consensus on Dusk Group Ltd. is a Moderate Buy with an average price target of A$1.60. DSK market cap is currently A$53.55M and has a P/E ratio of 9.30.
